Have your own idea? Try our Stock Screener
UPDATED Feb 15, 2025
Discover Norwegian Pharmaceuticals & Biotech Growth Stocks that are on the OSEAX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 57.60 | -1.2% | -1.0% | NOK 1.5b | NOK 84.50 | PE109x | E94.6% | 0% | ||
CRNA | NOK 0.63 | -1.9% | -90.0% | NOK 51.3m | NOK 2.00 | PE5.4x | E61.2% | n/a | ||
NAVA | NOK 21.60 | -11.5% | -43.0% | NOK 381.5m | NOK 37.00 | PE295.7x | E42.9% | n/a | ||
AZT | NOK 19.00 | 35.7% | -29.0% | NOK 970.4m | NOK 17.00 | PE128.2x | E17.2% | n/a | ||
NYKD | NOK 2.42 | -0.3% | -87.2% | NOK 788.9m | NOK 10.63 | PS16.2x | E-2.2% | n/a | ||
ABS | NOK 2.98 | -4.5% | -70.2% | NOK 75.6m | n/a | PS2.4x | E-12.8% | n/a | ||
BGBIO | NOK 7.77 | -4.0% | -65.1% | NOK 303.9m | NOK 20.00 | PS583.2x | E-23.5% | n/a | ||
ULTI | NOK 2.10 | 0.5% | -98.5% | NOK 72.1m | n/a | PB0.9x | n/a | n/a | ||
SOFTX | NOK 0.037 | 4.6% | -97.5% | NOK 71.4m | n/a | PS47x | n/a | n/a | ||
VISTN | NOK 23.70 | 0.9% | 0.9% | NOK 1.1b | n/a | PE16.7x | n/a | 4.2% | ||
EXTX | NOK 3.32 | -9.3% | -69.3% | NOK 210.0m | n/a | PB12x | n/a | n/a | ||
NORD | NOK 80.10 | -16.6% | 95.4% | NOK 398.2m | n/a | n/a | n/a | 0% | ||
ONCIN | NOK 2.20 | -12.0% | n/a | NOK 202.9m | NOK 3.50 | n/a | n/a | n/a | ||
HBC | NOK 2.77 | -9.2% | 15.4% | NOK 1.1b | n/a | PS4.3x | n/a | n/a | ||
LYTIX | NOK 5.54 | -4.5% | -14.8% | NOK 378.2m | NOK 14.00 | PS34x | S47.2% | n/a | ||
PCIB | NOK 1.33 | 7.8% | -30.8% | NOK 49.6m | n/a | PS8.3x | n/a | n/a | ||
TRMED | NOK 2.34 | -6.6% | 106.7% | NOK 735.7m | n/a | PB2.8x | n/a | n/a |